Seattle genetics reports q2 loss per share $0.12

Seattle genetics reports second quarter 2020 financial results.q2 revenue $278 million versus refinitiv ibes estimate of $256.4 million.q2 loss per share $0.12.q2 earnings per share estimate $-0.63 -- refinitiv ibes data.says total revenues are on track to exceed $1 billion in 2020.

SGEN Ratings Summary

SGEN Quant Ranking